Genta Inc. (GNTA.OB) Announces Progress with Global Phase III Genasense Melanoma Trial
Biopharmaceutical companies sometimes get a bad rep for their pricing and marketing tactics. But there are companies working within the biopharmaceutical industry that don’t follow the more typical processes associated with their larger brethren. These are the smaller companies working in the drug development trenches. Finding one of these workhorses can be difficult, but if they are found and nursed along, a nice profit can result. Genta Inc., a biopharmaceutical company, works to develop and market biopharmaceutical products directed at cancer and other small molecule applications. The company currently has a diverse portfolio of products at or nearing the end…